Methods Fifty-nine advanced NSCLC patients were divited into group A(TP chemotherapy alone) and group B (TP chemotherapy plus autologous CIK biotherapy).

• 方法59例患者分成A组（单用TP方案化疗）与B组（自体CIK联合TP方案治疗）。